221 related articles for article (PubMed ID: 25111953)
1. Inverse effect of mucinous component on survival in stage III colorectal cancer.
Ooki A; Akagi K; Yatsuoka T; Asayama M; Hara H; Yamamoto G; Nishimura Y; Yamaguchi K
J Surg Oncol; 2014 Dec; 110(7):851-7. PubMed ID: 25111953
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of mucinous histology depends on microsatellite instability status in patients with stage III colon cancer treated with adjuvant FOLFOX chemotherapy: a retrospective cohort study.
Kim SH; Shin SJ; Lee KY; Kim H; Kim TI; Kang DR; Hur H; Min BS; Kim NK; Chung HC; Roh JK; Ahn JB
Ann Surg Oncol; 2013 Oct; 20(11):3407-13. PubMed ID: 23943026
[TBL] [Abstract][Full Text] [Related]
3. The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: a Belgian multicentre prospective phase II clinical study.
Hompes D; D'Hoore A; Van Cutsem E; Fieuws S; Ceelen W; Peeters M; Van der Speeten K; Bertrand C; Legendre H; Kerger J
Ann Surg Oncol; 2012 Jul; 19(7):2186-94. PubMed ID: 22395983
[TBL] [Abstract][Full Text] [Related]
4. Lymph node evaluation in stage IIA colorectal cancer and its impact on patient prognosis: a population-based study.
Iachetta F; Reggiani Bonetti L; Marcheselli L; Di Gregorio C; Cirilli C; Messinese S; Cervo GL; Postiglione R; Di Emidio K; Pedroni M; Longinotti E; Federico M; Ponz de Leon M
Acta Oncol; 2013 Nov; 52(8):1682-90. PubMed ID: 23786176
[TBL] [Abstract][Full Text] [Related]
5. Defective Mismatch Repair Status was not Associated with DFS and OS in Stage II Colon Cancer Treated with Adjuvant Chemotherapy.
Kim JE; Hong YS; Kim HJ; Kim KP; Lee JL; Park SJ; Lim SB; Park IJ; Kim CW; Yoon YS; Yu CS; Kim JC; Hoon KJ; Kim TW
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S630-7. PubMed ID: 26271397
[TBL] [Abstract][Full Text] [Related]
6. Association of pathway mutation with survival after recurrence in colorectal cancer patients treated with adjuvant fluoropyrimidine and oxaliplatin chemotherapy.
Lee DW; Han SW; Cha Y; Bae JM; Kim HP; Lyu J; Han H; Kim H; Jang H; Bang D; Won JK; Jeong SY; Park KJ; Kang GH; Kim TY
BMC Cancer; 2019 May; 19(1):421. PubMed ID: 31060539
[TBL] [Abstract][Full Text] [Related]
7. Colorectal signet-ring cell carcinoma: benefit from adjuvant chemotherapy but a poor prognostic factor.
Hugen N; Verhoeven RH; Lemmens VE; van Aart CJ; Elferink MA; Radema SA; Nagtegaal ID; de Wilt JH
Int J Cancer; 2015 Jan; 136(2):333-9. PubMed ID: 24841868
[TBL] [Abstract][Full Text] [Related]
8. Mucinous rectal cancer: effectiveness of preoperative chemoradiotherapy and prognosis.
Shin US; Yu CS; Kim JH; Kim TW; Lim SB; Yoon SN; Yoon YS; Kim CW; Kim JC
Ann Surg Oncol; 2011 Aug; 18(8):2232-9. PubMed ID: 21347780
[TBL] [Abstract][Full Text] [Related]
9. Prognostic implication of mucinous histology in resected colorectal cancer liver metastases.
Lupinacci RM; Mello ES; Coelho FF; Kruger JA; Perini MV; Pinheiro RS; Fonseca GM; Cecconello I; Herman P
Surgery; 2014 Jun; 155(6):1062-8. PubMed ID: 24856126
[TBL] [Abstract][Full Text] [Related]
10. Prognostic implication of mucinous histology in colorectal cancer patients treated with adjuvant FOLFOX chemotherapy.
Lee DW; Han SW; Lee HJ; Rhee YY; Bae JM; Cho NY; Lee KH; Kim TY; Oh DY; Im SA; Bang YJ; Jeong SY; Park KJ; Park JG; Kang GH; Kim TY
Br J Cancer; 2013 May; 108(10):1978-84. PubMed ID: 23652310
[TBL] [Abstract][Full Text] [Related]
11. Is there a prognostic value of tumor location among Chinese patients with colorectal cancer?
Liu F; Li C; Jia H; Yang L; Wu Y; Zhao J; Cai S; Zhu J; Xu Y
Oncotarget; 2017 Jun; 8(24):38682-38692. PubMed ID: 28418874
[TBL] [Abstract][Full Text] [Related]
12. Prognoses of different pathological subtypes of colorectal cancer at different stages: A population-based retrospective cohort study.
Wu X; Lin H; Li S
BMC Gastroenterol; 2019 Oct; 19(1):164. PubMed ID: 31601167
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological, molecular features and prognosis of colorectal cancer with mucinous component.
Li J; Yang L; Bai F; Cai Y; Zhang J; Wu Z; Fu Y; Deng Y
Future Oncol; 2021 Apr; 17(11):1351-1362. PubMed ID: 33331169
[No Abstract] [Full Text] [Related]
14. Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study.
Chan JK; Tian C; Monk BJ; Herzog T; Kapp DS; Bell J; Young RC;
Cancer; 2008 May; 112(10):2202-10. PubMed ID: 18348296
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors affecting recurrence and survival in patients with locally advanced rectal cancer.
Koca D; Binicier C; Oztop I; Yavuzsen T; Ellidokuz H; Yilmaz U
J BUON; 2012; 17(2):291-8. PubMed ID: 22740208
[TBL] [Abstract][Full Text] [Related]
16. [Clinical features of colorectal mucinous adenocarcinoma].
Song W; He YL; Cai SR; Zhang CH; Chen CQ; Peng JJ; Zhan WH
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Sep; 12(5):487-90. PubMed ID: 19742341
[TBL] [Abstract][Full Text] [Related]
17. The clinicopathological features of colorectal mucinous adenocarcinoma and a therapeutic strategy for the disease.
Numata M; Shiozawa M; Watanabe T; Tamagawa H; Yamamoto N; Morinaga S; Watanabe K; Godai T; Oshima T; Fujii S; Kunisaki C; Rino Y; Masuda M; Akaike M
World J Surg Oncol; 2012 Jun; 10():109. PubMed ID: 22703761
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemotherapy with docetaxel-cisplatin in patients with stage III N2 non-small-cell lung cancer.
Liao WY; Chen JH; Wu M; Shih JY; Chen KY; Ho CC; Yang JC; Yu CJ
Clin Lung Cancer; 2013 Jul; 14(4):418-24. PubMed ID: 23291258
[TBL] [Abstract][Full Text] [Related]
19. Impact of complete cytoreduction leaving no gross residual disease associated with radical cytoreductive surgical procedures on survival in advanced ovarian cancer.
Chang SJ; Bristow RE; Ryu HS
Ann Surg Oncol; 2012 Dec; 19(13):4059-67. PubMed ID: 22766983
[TBL] [Abstract][Full Text] [Related]
20. Tumor budding is an independent predictor of outcome in AJCC/UICC stage II colorectal cancer.
Betge J; Kornprat P; Pollheimer MJ; Lindtner RA; Schlemmer A; Rehak P; Vieth M; Langner C
Ann Surg Oncol; 2012 Nov; 19(12):3706-12. PubMed ID: 22669453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
